High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer.

Zhang, Xuezhou; Liu, Jing; Yang, Xuecheng; Jiao, Wei; Shen, Chengquan; Zhao, Xinzhao; Wang, Yonghua

Zhang, Xuezhou; Liu, Jing; Yang, Xuecheng; Jiao, Wei; Shen, Chengquan; Zhao, Xinzhao; Wang, Yonghua.

Afiliação

Zhang X; Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Liu J; Department of Research Management and International Cooperation, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Yang X; Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Jiao W; Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Shen C; Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Zhao X; Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Wang Y; Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

Cell Cycle ; 22(5): 610-618, 2023 03.

Article em En | MEDLINE | ID: mdl-36474424

Assuntos

Proteômica; Neoplasias da Bexiga Urinária; Humanos; Cromatografia Líquida; Espectrometria de Massas em Tandem; Neoplasias da Bexiga Urinária/genética; Neoplasias da Bexiga Urinária/terapia; Imunoterapia; Microambiente Tumoral; Colágeno Tipo VI/genética

Palavras-chave

Bladder cancer; COL6A1; extracellular matrix; immunotherapy; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Proteômica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cell Cycle Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google